Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: FACTS not Fiction Re BOD Pay!

It is a reflection on their priorities. Clearly they are happy taking their "miniscule" compensation without little regard for shareholder value. It is an issue because PTSC is basically paying them to destroy shareholder wealth.

How else does $8M in quarterly revenue evaporate under their watch, under an agreement that they are responsible for? That is clearly something that makes a difference in share price. That's $0.02/share when shares are $0.10.

There's no need to "pick" on the BoD. Simple statement of facts is enough.

Share
New Message
Please login to post a reply